Molecular Platform Shows Promise for Detecting Asymptomatic Malaria Cases
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Category: Emerging & Zoonotic Diseases
Emerging & Zoonotic Diseases
Latest
Emerging & Zoonotic Diseases
Latest
Labcorp Launches H5 Bird Flu Test
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Emerging & Zoonotic Diseases
Latest
Abbott Survey Reveals Gaps in Pandemic Preparedness
Abbott's Pandemic Preparedness Survey found significant gaps remain in surveillance programs and testing infrastructure capabilities.
P. Vivax Malaria Biomarkers Associated with Recurrence Identified
Brazilian researchers identified potential biomarkers linked to the recurrence of P. vivax malaria, providing insights for drug development.
Read More
Diagnostic Testing Is First Line of Defense Against H5N1
H5N1 avian flu, historically infecting birds, has recently infected three farm workers. Diagnostic testing may be our best defense.
Read More
Mystery Solved: Escherichia Albertii Causing Symptoms in Children
The development of a quantitative real-time PCR method by researchers enhances the detection of Escherichia Albertii.
Read More
New Biomarker Tech Differentiates Between Zika and Dengue Infections
A study detailed a new Zika virus-specific synthetic molecule that effectively distinguishes Zika from related dengue virus infections.
Read More
University Develops Urine Test for Early Lyme Disease Detection
George Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read More
Labcorp’s Mpox PCR Home Test Kit Granted FDA’s EUA
The FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read More
A New, Faster Point-of-Care Malaria Test Gets Developed
Researchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
Read More
Researchers Identify Hantavirus Through New Rapid Test to Curb Potential Outbreaks
A study showcased the application of Flongle sequencing as a cost-efficient and rapid method to detect the zoonotic pathogen.
Read More
How Disease Surveillance Will Help Spot Disease X
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read More
Black Individuals More Likely to Experience Inequities in Lyme Disease Diagnosis
A new study has revealed disparities in the diagnosis and treatment of Lyme disease between Black and White patients with the condition.
Read More
Self-Sampling Proves Effective for Asymptomatic Mpox Diagnosis
A pilot study demonstrated the importance of self-sampling in diagnosing asymptomatic or atypical cases of mpox.
Read More
Scientists Find Flaw in Malaria Diagnostics
Current diagnostic methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood.
Read More
New Mpox Rapid Test is Adaptable for Other Diseases
A rapid test for mpox has been developed that can detect the virus within minutes, without the use of any high-end instrumental techniques.
Read More
Startup Gets $1 Million Grant to Build Infectious Disease Breathalyzer
Noze received a grant of $1 million to build a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs).
Read More
Cue Health’s Molecular Mpox Test Gets FDA EUA
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read More